The high levels of collagen I, C-MYC, SIRT1, COX2, and RAD51 expression in the tumor are attenuated by the treatment, leading to reduced fibrosis, viability, inflammation, culminating in cancer cell death. This evidence concerns the gene RAD51 and cancer.